Nearly two decades ago, the Medtech and Healthtech industries as they stand today were nascent. The Human Genome Project had just been completed, which began to open new avenues for personalized medicine and genomics-based diagnostics. Intuitive Surgical closed their fiscal year 2003 with $91.7 million in total sales, as robotic surgery had begun to reach prostatectomies, cardiac valve repair, and gynecologic surgeries. Early health monitoring devices like heart rate monitors and basic fitness trackers had begun to gain some popularity among consumers. 

LSI was similarly in its infancy. Our method of providing market data to clients? Hardcover binders with hundreds of pages of printed information, maybe a fax if we were lucky. Invitations for our events? All over the phone, and not a smart one. 

The spirit of innovation from the early innings of Medtech and Healthtech has led to the remarkable healthcare breakthroughs we see today. Similarly, as the industry has evolved, LSI has made meaningful strides in our ability to better power smarter decisions and stronger partnerships that enable Medtech and Healthtech executives to grow breakthrough businesses, faster.

This week, we announced another one of those strides that we anticipate will be a seminal moment in our ability to support the industry we love – the launch of LSI Asia, the third geography in our global LSI Emerging Medtech Summit series, which will be inaugurated with LSI Asia ‘25 at The Ritz-Carlton, Millenia Singapore on June 10th - 13th, 2025.

The Right Time to Launch in Asia 

The decision to launch LSI Asia is a response to the evolving dynamics of the global medtech industry and our growing global community. Over the past few years, we have witnessed the Asia Pacific region emerge as a hotbed for innovation, capital, manufacturing, and business development. 

We’ve seen a shift from “me too” plays in the region to globally-consequential innovation at the forefront of Deep Tech, Robotics, AI, and more. Chronic diseases like diabetes, cardiovascular diseases, cancers, and diseases of aging are driving policy, necessitating investment, and seeding a vibrant startup ecosystem. LSI’s Market Intelligence team even projects that China will surpass the United States in total volume of tracked surgical procedures in 2024, with four of the five fastest growing countries in total volume being in Asia (China, India, South Korea, Singapore).

This region is no longer just an emerging player; it is a critical driver of global medtech growth.

For executives operating outside of Asia, the region represents a "next frontier." Asia is characterized by a rapidly growing ecosystem of medical device startups, significant LP and investment activity, and the presence of major strategic players. 

This convergence of factors makes it the perfect time to establish a dedicated platform that caters to the unique needs and opportunities in the region, showcases both local and global innovation, and facilitates strategic partnerships domestically and across borders.

Why Singapore is the Right Place

Singapore's rise as a leading startup ecosystem is nothing short of remarkable. It has risen to be on similar footing as traditional powerhouses like Beijing, backed by a supportive government, prominent institutional investors, sovereign wealth funds, family offices and high-net-worth individuals, and attractive tax and financial structures that inspire flexible and efficient innovation and investment activity.

Singapore's medtech sector is particularly noteworthy. The country's commitment to fostering a conducive environment for medical device development, innovation, and manufacturing is evident by its outsized production of locally-made medical devices that punch above their weight on the global stage. The synergy between public policy, private enterprise, and academic research has created a positive feedback loop to nurture startups and attract capital at scale.

Often referred to as a “gateway” to Southeast Asia, Singapore's strategic location makes it an ideal hub for connecting executives across Asia with one another, and with our established global community built through our parallel events in the USA and Europe.

And of course, in selecting a location, it is paramount that we stay true to our ethos and find a world-class venue where senior executives can do real business. The Ritz-Carlton, Millenia Singapore is an award-winning, five-star property with authentic Cantonese Michelin star restaurants, panoramic views, spacious accommodations, and state-of-the-art meeting and AV facilities. I’m confident our guests won’t mind stopping by Republic bar either, which ranks among one of Asia's 50 Best Bars.

Our Future in Asia

As we look to the future, LSI Asia ‘25 is just the beginning. The region's dynamic ecosystem and growing influence on the global stage make it the perfect geography for our third Emerging Medtech Summit series. By launching LSI Asia, we are not just responding to the influence and potential of the region today, but aspire to actively contribute to its realization.

We believe that by helping executives access the community, capital and insights that enable growth, we can help build a future where more cutting-edge technologies save and improve lives worldwide. 

Join us at LSI Asia ‘25

With registration, applications for presenters, calls for speakers, sponsorship opportunities, and our hotel block at The Ritz-Carlton, Millenia Singapore now open, I invite you to secure your spot and join us for LSI Asia 2025. Whether you are an innovator, investor, strategic, or value-add professional service provider, LSI Asia ‘25 will offer a unique forum to connect, collaborate, and accelerate your business.

Visit our LSI Asia website to learn more about the event. Together, let's take another step forward in building breakthrough Medtech and Healthtech businesses that save and improve lives.

– Scott Pantel, CEO & Founder, LSI